Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Athena Diagnostics | RCV001508479 | SCV004229374 | uncertain significance | not provided | 2022-12-19 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity (http://gnomad.broadinstitute.org). Computational tools disagree on the variant's effect on normal protein function. |
| Revvity Omics, |
RCV001508479 | SCV003819759 | uncertain significance | not provided | 2019-05-21 | criteria provided, single submitter | clinical testing | |
| Mayo Clinic Laboratories, |
RCV001508479 | SCV001714659 | uncertain significance | not provided | 2019-10-09 | criteria provided, single submitter | clinical testing | |
| CHEO Genetics Diagnostic Laboratory, |
RCV000769074 | SCV000900447 | uncertain significance | Cardiomyopathy | 2017-01-09 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000228104 | SCV000286470 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-01-23 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV001508479 | SCV000238247 | likely benign | not provided | 2018-10-11 | criteria provided, single submitter | clinical testing |